A Dose Finding Study of Remifentanil and Propofol for Lumbar Punctures in Children
Hematologic Diseases, Neoplasms
About this trial
This is an interventional treatment trial for Hematologic Diseases focused on measuring spinal puncture, remifentanil, propofol, anesthesia, dose finding, pediatrics
Eligibility Criteria
Inclusion Criteria: Clinical diagnosis of a hemato-oncological disorder Scheduled to undergo a lumbar puncture Aged 4-11 years Male or female Unpremedicated Willing and able to provide informed consent (or informed consent by parents) Exclusion Criteria: Children who are known or suspected to be difficult to ventilate by face mask Children who are deemed medically unfit to receive either of the two study medications Children who are obese (weight for height > 95th percentile, Children who do not have an indwelling intravenous line
Sites / Locations
- The Hospital for Sick Children
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Propofol 4 mg/kg group
Propofol 2 mg/kg group
First patient in this arm will receive a bolus of propofol 4 mg/kg followed by remifentanil 0.5 mcg/kg. Subsequent patients randomized to this arm will receive propofol 4 mg/kg but the dose of remifentanil will be determined using the Dixon up-and-down method (i.e. based on the response of the previous patient)
First patient in this arm will receive a bolus of propofol 2 mg/kg followed by remifentanil 1 mcg/kg. Subsequent patients randomized to this arm will receive propofol 2 mg/kg but the dose of remifentanil will be determined using the Dixon up-and-down method (i.e. based on the response of the previous patient)